Almeda Ventures Limited Partnership (TLV:AMDA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 225.20
+3.90 (1.76%)
At close: Mar 5, 2026
TLV:AMDA Revenue
Almeda Ventures Limited Partnership had revenue of $-983.00K USD in the half year ending June 30, 2025, with 217.10% growth. This brings the company's revenue in the last twelve months to $-3.23M, up 328.69% year-over-year. In the year 2024, Almeda Ventures Limited Partnership had annual revenue of $-3.02M with 932.88% growth.
Revenue (ttm)
$-3.23M
Revenue Growth
+328.69%
P/S Ratio
-4.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
43.68M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | -3.02M | -2.72M | 932.88% |
| Dec 31, 2023 | -292.00K | -1.20M | -132.19% |
| Dec 31, 2022 | 907.00K | -690.00K | -43.21% |
| Dec 31, 2021 | 1.60M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Together Pharma | 109.22M |
| Clal Biotechnology Industries | 91.00K |
| Merchavia Holdings and Investments | -2.92M |
| BioLineRx | 42.17M |